DNAJB6
Basic information
Region (hg38): 7:157335381-157417439
Previous symbols: [ "LGMD1D" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) (Supportive), mode of inheritance: AD
- autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) (Strong), mode of inheritance: AD
- muscular dystrophy, limb-girdle, autosomal dominant (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Muscular dystrophy, limb-girdle, autosomal dominant 1 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 22334415; 22366786; 24594375; 26205529; 30055862 |
ClinVar
This is a list of variants' phenotypes submitted to
- Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) (9 variants)
- not provided (5 variants)
- Abnormality of the musculature (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAJB6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 55 | 57 | ||||
missense | 137 | 155 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 3 | 9 | 1 | 13 | ||
non coding | 36 | 69 | 38 | 143 | ||
Total | 9 | 2 | 193 | 131 | 40 |
Highest pathogenic variant AF is 0.00000657
Variants in DNAJB6
This is a list of pathogenic ClinVar variants found in the DNAJB6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-157337063-C-A | Myofibrillar Myopathy, Dominant • Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Uncertain significance (Jan 13, 2018) | ||
7-157337078-G-T | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) • Limb-Girdle Muscular Dystrophy, Dominant | Uncertain significance (Jan 12, 2018) | ||
7-157337085-G-A | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) • Myofibrillar Myopathy, Dominant | Benign/Likely benign (May 26, 2021) | ||
7-157337086-G-T | Myofibrillar Myopathy, Dominant • Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Conflicting classifications of pathogenicity (Jan 12, 2018) | ||
7-157337094-G-A | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Uncertain significance (Jan 13, 2018) | ||
7-157337108-C-G | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Benign/Likely benign (Nov 21, 2021) | ||
7-157337128-G-T | Myofibrillar Myopathy, Dominant • Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Benign/Likely benign (Jan 12, 2018) | ||
7-157337288-C-T | Benign (Jul 03, 2018) | |||
7-157337335-A-T | Benign (Jul 03, 2018) | |||
7-157358329-C-T | Benign (Jun 14, 2018) | |||
7-157358492-C-T | Likely benign (Sep 18, 2018) | |||
7-157358540-C-T | not specified • Limb-Girdle Muscular Dystrophy, Dominant • Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Benign (Jul 30, 2021) | ||
7-157358565-C-G | Uncertain significance (Sep 07, 2017) | |||
7-157358565-C-T | Uncertain significance (Mar 04, 2016) | |||
7-157358566-G-A | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Uncertain significance (Jan 13, 2018) | ||
7-157358593-T-G | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Likely benign (Aug 30, 2021) | ||
7-157358599-C-T | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Likely benign (Oct 05, 2022) | ||
7-157358612-G-T | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Uncertain significance (Sep 01, 2023) | ||
7-157358616-C-CA | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Uncertain significance (Mar 08, 2022) | ||
7-157358620-C-A | DNAJB6-related disorder | Likely benign (Aug 14, 2024) | ||
7-157358620-C-G | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Likely benign (Mar 10, 2022) | ||
7-157358620-C-T | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) • not specified • DNAJB6-related disorder | Conflicting classifications of pathogenicity (Jan 29, 2024) | ||
7-157358621-G-T | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Uncertain significance (Sep 17, 2022) | ||
7-157358624-G-A | DNAJB6-related disorder • Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) • Inborn genetic diseases | Uncertain significance (Nov 20, 2024) | ||
7-157358627-A-G | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | Uncertain significance (Jun 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNAJB6 | protein_coding | protein_coding | ENST00000262177 | 9 | 82059 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.854 | 0.146 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.17 | 148 | 194 | 0.763 | 0.0000122 | 2100 |
Missense in Polyphen | 21 | 36.162 | 0.58071 | 403 | ||
Synonymous | -1.16 | 96 | 82.6 | 1.16 | 0.00000592 | 620 |
Loss of Function | 3.46 | 3 | 19.5 | 0.154 | 0.00000124 | 215 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000996 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000332 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an indispensable role in the organization of KRT8/KRT18 filaments. Acts as an endogenous molecular chaperone for neuronal proteins including huntingtin. Suppresses aggregation and toxicity of polyglutamine-containing, aggregation-prone proteins. Isoform B but not isoform A inhibits huntingtin aggregation. Has a stimulatory effect on the ATPase activity of HSP70 in a dose-dependent and time-dependent manner and hence acts as a co-chaperone of HSP70. Also reduces cellular toxicity and caspase-3 activity. {ECO:0000269|PubMed:10954706, ECO:0000269|PubMed:11896048, ECO:0000269|PubMed:20159555, ECO:0000269|PubMed:22366786, ECO:0000269|PubMed:28233300}.;
- Disease
- DISEASE: Limb-girdle muscular dystrophy 1E (LGMD1E) [MIM:603511]: An autosomal dominant myopathy characterized by adult onset of proximal muscle weakness, beginning in the hip girdle region and later progressing to the shoulder girdle region. {ECO:0000269|PubMed:22334415, ECO:0000269|PubMed:22366786}. Note=The disease is caused by mutations affecting the gene represented in this entry. There is evidence that LGMD1E is caused by dysfunction of isoform B (PubMed:22366786). {ECO:0000269|PubMed:22366786}.;
- Pathway
- Cellular response to heat stress;HSF1 activation;Attenuation phase;HSF1-dependent transactivation;prion pathway;Regulation of HSF1-mediated heat shock response;Cellular responses to stress;Cellular responses to external stimuli;Cellular response to heat stress
(Consensus)
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.477
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.29
Haploinsufficiency Scores
- pHI
- 0.342
- hipred
- Y
- hipred_score
- 0.633
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnajb6
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- dnajb6a
- Affected structure
- skeletal muscle
- Phenotype tag
- abnormal
- Phenotype quality
- refractivity
Gene ontology
- Biological process
- protein folding;actin cytoskeleton organization;extracellular matrix organization;positive regulation of ATPase activity;regulation of protein localization;protein localization to nucleus;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;intermediate filament organization;negative regulation of transcription, DNA-templated;chorio-allantoic fusion;syncytiotrophoblast cell differentiation involved in labyrinthine layer development;chorion development;negative regulation of inclusion body assembly;regulation of cellular response to heat
- Cellular component
- nucleus;nucleoplasm;cytosol;membrane;Z disc;perinuclear region of cytoplasm
- Molecular function
- ATPase activator activity;DNA binding;protein binding;heat shock protein binding;unfolded protein binding;chaperone binding